Cwm, LLC Adma Biologics, Inc. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 11,798 shares of ADMA stock, worth $231,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,798

Previous 14,129 16.5%

Holding current value

$231,830

Previous $282,000 28.37%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$15.62 - $22.62 $36,410 - $52,727	-2,331 Reduced 16.5%	11,798 $202,000
Q3 2024 Oct 08, 2024	BUY	$11.21 - $20.03 $66,553 - $118,918	5,937 Added 72.47%	14,129 $282,000
Q2 2024 Jul 09, 2024	BUY	$5.98 - $11.18 $26,114 - $48,823	4,367 Added 114.17%	8,192 $92,000
Q1 2024 Apr 05, 2024	BUY	$4.4 - $6.74 $15,782 - $24,176	3,587 Added 1507.14%	3,825 $25,000
Q4 2023 Feb 01, 2024	SELL	$3.08 - $4.52 $36 - $54	-12 Reduced 4.8%	238 $1,000
Q3 2023 Oct 11, 2023	BUY	$3.47 - $4.61 $41 - $55	12 Added 5.04%	250 $1,000
Q4 2022 Feb 01, 2023	BUY	$2.47 - $3.88 $587 - $923	238 New	238 $1,000

Others Institutions Holding ADMA

# of Institutions

339

Shares Held

182M

Call Options Held

1.72M

Put Options Held

846K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.86B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account